about
Analysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated ControlsGenome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis.Peripheral nociceptor sensitization mediates allodynia in patients with distal symmetric polyneuropathy.Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia.Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity.Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review.Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia.Persistence of a large population of exhausted monoclonal B cells in mixed cryoglobuliemia after the eradication of hepatitis C virus infection.The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy.Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia.Cl- regulates cryoglobulin structure: a new hypothesis for the physiopathological mechanism of temperature non-dependent cryoprecipitation.Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia.Hepatitis C virus and nephrotic syndrome.Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21 low cells overexpressing Stra13.Expression of biomarkers of interferon type I in patients suffering from chronic diseasesTreatment of idiopathic mixed cryoglobulinemia with alpha interferonCryoglobulinaemia and alpha-interferonGranulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicityMixed cryoglobulinemia secondary to visceral LeishmaniasisAnalysis of the dynamics of cryoaggregation by light-scattering spectrometryDifferent genomic imbalances in low- and high-grade HCV-related lymphomasThe V(H)1-69-expressing marginal zone B cells expanded in HCV-associated mixed cryoglobulinemia display proliferative anergy irrespective of CD21(low) phenotypeHBV messing with the B-cell genome leads to DLBCLLong-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis
P50
Q27480341-E7B4358A-AB6A-4956-B764-73EFE6C7A807Q34401717-7BFCC539-2C16-4597-9A81-855A1DB8B010Q34439631-CEDAA0F5-ED6E-4C95-8723-2DEE02297121Q34579182-78C45938-F0BF-43BF-964C-0757512B93D7Q35087093-79662E00-CADD-4F61-98F3-62769C14A206Q38039818-474BC094-1343-4000-B0BF-5B1420E1DA86Q38511178-92AE3AB8-EA98-450D-85A6-9ED823D75CD8Q38878808-EEB6AF37-412E-4817-B7D7-326D90A747A5Q40200480-5648A9C1-77BA-4BC5-8F90-CA07D5902E81Q42978121-1A0380B9-C0B0-4152-83BE-3BAF0565A5ACQ43040151-BB654A05-3B1D-4ECA-B1E2-452BB099CF3AQ44100312-3147D53C-61E7-43D2-B4DC-DA4978D6A404Q44983081-93E4E3BB-9821-45F9-89A0-F66BB49D8694Q45733494-FF2A510C-50FA-42BB-BE6F-B50A67F53AF2Q45739213-D65840CA-8A76-4D4C-B880-8C3E18DCBDE5Q54505741-7055950B-23BC-4692-BB17-280DAB6AB137Q57632335-370D3924-35E9-48C3-B568-5BB59EFF5151Q69436993-249596A1-595E-4652-B28C-AED85A3AAB07Q69920931-6E0BEF42-F3D1-4585-ABD1-494851BB91B0Q71775352-072D28C4-91B5-4017-800C-B531CB00C4D8Q73065176-B8C2C042-B469-48F1-822E-F4D88192ED9AQ73196418-1F89359F-19DE-4534-B328-2FBBD08417CAQ80777933-B637A3EB-6B8C-48FE-A383-1D4B8118D97CQ84975516-34DF0987-3EE9-4178-820F-65B450B9C23EQ89107775-062869E6-71DE-4759-88C2-998B9209E08AQ91253680-60E3ED80-592A-4B19-B5DC-9F4AC6717549
P50
description
researcher, ORCID id # 0000-0003-1841-6808
@en
wetenschapper
@nl
name
Milvia Casato
@ast
Milvia Casato
@en
Milvia Casato
@es
Milvia Casato
@nl
type
label
Milvia Casato
@ast
Milvia Casato
@en
Milvia Casato
@es
Milvia Casato
@nl
prefLabel
Milvia Casato
@ast
Milvia Casato
@en
Milvia Casato
@es
Milvia Casato
@nl
P106
P1153
6701321839
P31
P496
0000-0003-1841-6808